Methocarbamol NDC 0276-0510

NDC codes

FDA NDC Directory

Product NDC (as listed)0276-0510Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00276-0510Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0276-0510-10	00276051010	100 TABLET, COATED in 1 BOTTLE, PLASTIC (0276-0510-10)Marketed from Sep 13, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methocarbamol
Generic name (nonproprietary): methocarbamol
Active ingredients: Methocarbamol — 1000 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Misemer Pharmaceutical
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200958
Marketing start: Sep 13, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 0276-0510_4d4ff388-0c6c-54ba-e063-6294a90a8bb7SPL ID 4d4ff388-0c6c-54ba-e063-6294a90a8bb7SPL set ID e89ae224-ed25-4ae7-e053-2a95a90a9c0eRxCUI 2611794UNII 125OD7737X
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400276051010 followed by a unit qualifier and the quantity

Package 00276-0510-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 18, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200958

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200958
Product	Strength	Form · route	Labeler	Product NDC
Methocarbamol	Methocarbamol 1000 mg/1	Tablet, CoatedOral	Trifluent Pharma LLC	73352-510
Methocarbamol	Methocarbamol 750 mg/1	Tablet, CoatedOral	Bostal LLC	35561-211
Methocarbamol	Methocarbamol 500 mg/1	Tablet, CoatedOral	Bostal LLC	35561-212
Methocarbamol	Methocarbamol 1000 mg/1	Tablet, CoatedOral	Oncora Pharma, LLC	85477-101
Methocarbamol	Methocarbamol 1000 mg/1	Tablet, CoatedOral	Bostal LLC	35561-349